These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7168940)

  • 1. [Generating mechanism and treatment of parkinsonian symptoms].
    Narabayashi H
    Rinsho Shinkeigaku; 1982 Dec; 22(12):1055-62. PubMed ID: 7168940
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parkinsonian syndrome. Etiology, diagnosis, treatment].
    Montastruc JL
    Rev Prat; 1990 Nov; 40(27):2555-9. PubMed ID: 1980547
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebral blood flow in Parkinson's syndrome.
    Granérus AK; Nilsson NJ; Suurküla M; Svanborg A
    Adv Neurol; 1984; 40():403-5. PubMed ID: 6695620
    [No Abstract]   [Full Text] [Related]  

  • 4. [Parkinson syndrome, frontal tumor and L-dopa].
    Lhermitte F; Agid Y; Serdaru M; Guimaraes J
    Rev Neurol (Paris); 1984; 140(2):138-9. PubMed ID: 6710014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with a l-dopa retard preparation in the peroral long-term therapy of the Parkinsonian syndrome].
    Binder H; Gerstenbrand F; Grünberger J; Gründig E; Schubert H
    Nervenarzt; 1976 Nov; 47(11):656-60. PubMed ID: 826840
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and biochemical considerations on depressive states occuring during parkinsonian syndrome treated by L-Dopa].
    Gisselmann A; Boudry C; Marin A; Ballivet J
    Encephale; 1976; 2(2):105-13. PubMed ID: 1278088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in therapy of Parkinsonian syndrome].
    Völler GW
    Hippokrates; 1975 Feb; 46(1):17-33. PubMed ID: 1091605
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cognition disorders and parkinsonian syndrome: diffuse Lewy body disease?].
    Etcharry-Bouyx F; Gambarelli D; Kassis N; Gosset A; Bonnefoi-Kyriacou B; Viallet F
    Rev Neurol (Paris); 1995; 151(6-7):410-2. PubMed ID: 7481406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current treatment of Parkinsonian syndrome].
    Lechner H; Bertha G; Ott E
    Med Welt; 1980 Oct; 31(40):1444-6. PubMed ID: 7464500
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis.
    Nygaard TG
    Adv Neurol; 1993; 60():577-85. PubMed ID: 8420194
    [No Abstract]   [Full Text] [Related]  

  • 11. Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys.
    Miyoshi Y; Zhang Z; Ovadia A; Lapchak PA; Collins F; Hilt D; Lebel C; Kryscio R; Gash DM
    Ann Neurol; 1997 Aug; 42(2):208-14. PubMed ID: 9266731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brainstem myoclonus in a patient with non-dopa-responsive parkinsonism.
    Clouston PD; Lim CL; Fung V; Yiannikas C; Morris JG
    Mov Disord; 1996 Jul; 11(4):404-10. PubMed ID: 8813220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of liposomal form of L-Dopa on the development of parkinsonian syndrome in mice].
    Kucherianu VG; Iurasov VV; Kryzhanovskiĭ GN; Nikushkin EV; Zhigal'tsev IV; Kaplun VP; Shvets VI
    Biull Eksp Biol Med; 1997 Jan; 123(1):29-33. PubMed ID: 9213451
    [No Abstract]   [Full Text] [Related]  

  • 14. [Letter: Malignant melanoma during treatment with levodopa].
    Pelfréne AF
    Nouv Presse Med; 1975 May; 4(18):1365. PubMed ID: 1153302
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinsonian manifestations in a patient with homocystinuria.
    Keskin S; Yurdakul F
    J Child Neurol; 1996 May; 11(3):235-6. PubMed ID: 8734028
    [No Abstract]   [Full Text] [Related]  

  • 16. Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications.
    Chase TN; Oh JD
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S122-9; discussion S129-30. PubMed ID: 10762139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group.
    Ann Neurol; 1996 Jan; 39(1):37-45. PubMed ID: 8572664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of disorders of "non-specific systems" of the brain in the pathogenesis of the Parkinsonian syndrome].
    Veĭn AM; Golubev VL; Iakhno NN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(7):970-5. PubMed ID: 1210989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Crises in the course of Parkinson's disease].
    Danielczyk W
    Wien Med Wochenschr; 1980 Feb; 130(4):149-51. PubMed ID: 7376682
    [No Abstract]   [Full Text] [Related]  

  • 20. "Apraxia of eyelid opening" induced by levodopa therapy and apomorphine in atypical parkinsonism (possible progressive supranuclear palsy): a case report.
    Defazio G; De Mari M; De Salvia R; Lamberti P; Giorelli M; Livrea P
    Clin Neuropharmacol; 1999; 22(5):292-4. PubMed ID: 10516881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.